144
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Risk Factors for the Absence of Diagnosis of Asthma Despite Disease Symptoms: Results from the Swedish GA2LEN Study

, , , , , , & ORCID Icon show all
Pages 179-186 | Published online: 09 Feb 2022

References

  • Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31(1):143–178. doi:10.1183/13993003.51387-2007
  • Diseases GBD, Injuries C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204–1222. doi:10.1016/S0140-6736(20)30925-9
  • Kavanagh J, Jackson DJ, Kent BD. Over- and under-diagnosis in asthma. Breathe. 2019;15(1):e20–e27. doi:10.1183/20734735.0362-2018
  • Aaron SD, Boulet LP, Reddel HK, Gershon AS. Underdiagnosis and overdiagnosis of asthma. Am J Respir Crit Care Med. 2018;198(8):1012–1020. doi:10.1164/rccm.201804-0682CI
  • van Schayck CP, van Der Heijden FM, van Den Boom G, Tirimanna PR, van Herwaarden CL. Underdiagnosis of asthma: is the doctor or the patient to blame? The DIMCA project. Thorax. 2000;55(7):562–565. doi:10.1136/thorax.55.7.562
  • Aaron SD, Vandemheen KL, Boulet L-P, et al. Overdiagnosis of asthma in obese and nonobese adults. CMAJ. 2008;179(11):1121–1131. doi:10.1503/cmaj.081332
  • Hunter CJ, Brightling CE, Woltmann G, Wardlaw AJ, Pavord ID. A comparison of the validity of different diagnostic tests in adults with asthma. Chest. 2002;121(4):1051–1057. doi:10.1378/chest.121.4.1051
  • Emerman CL, Cydulka RK. Effect of pulmonary function testing on the management of acute asthma. Arch Intern Med. 1995;155(20):2225–2228. doi:10.1001/archinte.1995.00430200117015
  • Accordini S, Cappa V, Braggion M, et al. The impact of diagnosed and undiagnosed current asthma in the general adult population. Int Arch Allergy Immunol. 2011;155(4):403–411. doi:10.1159/000320780
  • Kuprys-Lipinska I, Liebhart J, Palczynski C, et al. Prevalence, risk factors and underdiagnosis of asthma in the general population aged over 60 years. Postepy Dermatol Alergol. 2019;36(1):86–91. doi:10.5114/ada.2018.73330
  • Gonzalez-Garcia M, Caballero A, Jaramillo C, Maldonado D, Torres-Duque CA. Prevalence, risk factors and underdiagnosis of asthma and wheezing in adults 40 years and older: a population-based study. J Asthma. 2015;52(8):823–830. doi:10.3109/02770903.2015.1010733
  • Annesi-Maesano I, Sterlin C, Caillaud D, et al. Factors related to under-diagnosis and under-treatment of childhood asthma in metropolitan France. Multidiscip Respir Med. 2012;7(1):24. doi:10.1186/2049-6958-7-24
  • Siersted HC, Boldsen J, Hansen HS, Mostgaard G, Hyldebrandt N. Population based study of risk factors for underdiagnosis of asthma in adolescence: Odense schoolchild study. BMJ. 1998;316(7132):651–655; discussion 655–656. doi:10.1136/bmj.316.7132.651
  • Bousquet J, Burney PG, Zuberbier T, et al. GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma ‘epidemic’. Allergy. 2009;64(7):969–977. doi:10.1111/j.1398-9995.2009.02059.x
  • Sundbom F, Lindberg E, Bjerg A, et al. Asthma symptoms and nasal congestion as independent risk factors for insomnia in a general population: results from the GA(2)LEN survey. Allergy. 2013;68(2):213–219. doi:10.1111/all.12079
  • Bjerg A, Ekerljung L, Middelveld R, et al. Increased prevalence of symptoms of rhinitis but not of asthma between 1990 and 2008 in Swedish adults: comparisons of the ECRHS and GA(2)LEN surveys. PLoS One. 2011;6(2):e16082. doi:10.1371/journal.pone.0016082
  • Bjornsson E, Plaschke P, Norrman E, et al. Symptoms related to asthma and chronic bronchitis in three areas of Sweden. Eur Respir J. 1994;7(12):2146–2153. doi:10.1183/09031936.94.07122146
  • Jerning C, Martinander E, Bjerg A, et al. Asthma and physical activity–a population based study results from the Swedish GA(2)LEN survey. Respir Med. 2013;107(11):1651–1658. doi:10.1016/j.rmed.2013.08.040
  • Thomas M, Yawn B, Price D, et al. EPOS primary care guidelines: European position paper on the primary care diagnosis and management of rhinosinusitis and nasal polyps 2007 - a summary. Prim Care Respir J. 2008;17(2):79–89. doi:10.3132/pcrj.2008.00029
  • Dharmage SC, Perret JL, Custovic A. Epidemiology of asthma in children and adults. Front Pediatr. 2019;7:246. doi:10.3389/fped.2019.00246
  • Bloom CI, Nissen F, Douglas IJ, et al. Exacerbation risk and characterisation of the UK’s asthma population from infants to old age. Thorax. 2018;73(4):313–320. doi:10.1136/thoraxjnl-2017-210650
  • Janson C, Chinn S, Jarvis D, Burney P. Individual use of antiasthmatic drugs in the European Community Respiratory Health Survey. Eur Respir J. 1998;12(3):557–563. doi:10.1183/09031936.98.12030557
  • Janson C, Accordini S, Cazzoletti L, et al. Pharmacological treatment of asthma in a cohort of adults during a 20-year period: results from the European Community Respiratory Health Survey I, II and III. ERJ Open Res. 2019;5(1):00073–2018. doi:10.1183/23120541.00073-2018
  • Dunn RM, Busse PJ, Wechsler ME. Asthma in the elderly and late-onset adult asthma. Allergy. 2018;73(2):284–294. doi:10.1111/all.13258
  • Adams RJ, Wilson DH, Appleton S, et al. Underdiagnosed asthma in South Australia. Thorax. 2003;58(10):846–850. doi:10.1136/thorax.58.10.846
  • Walters N, Coleman T. Comparison of the smoking behaviour and attitudes of smokers who attribute respiratory symptoms to smoking with those who do not. Br J Gen Pract. 2002;52(475):132–134.
  • Society BH. Drug classes: angiotensin converting enzyme (ACE) inhibitors; 2017. Available from: https://bihsoc.org/wp-content/uploads/2017/11/Angiotensin-Converting-Enzyme-Final-2017.pdf. Accessed December 21, 2021.
  • Polosa R, Holgate ST. Comparative airway response to inhaled bradykinin, kallidin, and [des-Arg9]bradykinin in normal and asthmatic subjects. Am Rev Respir Dis. 1990;142:1367–1371. doi:10.1164/ajrccm/142.6_Pt_1.1367
  • He Z, Feng J, Xia J, et al. Frequency of signs and symptoms in persons with asthma. Respir Care. 2020;65(2):252–264. doi:10.4187/respcare.06714
  • Morin CM, LeBlanc M, Daley M, Gregoire JP, Merette C. Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med. 2006;7(2):123–130. doi:10.1016/j.sleep.2005.08.008
  • Leander M, Lampa E, Rask-Andersen A, et al. Impact of anxiety and depression on respiratory symptoms. Respir Med. 2014;108(11):1594–1600. doi:10.1016/j.rmed.2014.09.007
  • Toskala E, Kennedy DW. Asthma risk factors. Int Forum Allergy Rhinol. 2015;Suppl 5(S1):S11–16. doi:10.1002/alr.21557
  • Greenberg H, Cohen RI. Nocturnal asthma. Curr Opin Pulm Med. 2012;18(1):57–62. doi:10.1097/MCP.0b013e32834d098e